Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

Publisher： Karger

E-ISSN： 2296-5262|30|4|185-191

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.4, 2007-03, pp. : 185-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine

By  

MYCOSES (ELECTRONIC), Vol. 42, Iss. S2, 1999-12 ,pp. : 101-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Micafungin as an Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-07 ,pp. : 92-97

Karger

Access to resources Recommend Favorite

Antifungal prophylaxis with itraconazole oral solution in neutropenic patients

By  

MYCOSES (ELECTRONIC), Vol. 42, Iss. S2, 1999-12 ,pp. : 121-124

John Wiley & Sons Inc

Access to resources Recommend Favorite